Frequently asked questions

AlmirallShare is an open innovation platform designed to share efforts and work together to find innovative solutions in skin health

AlmirallShare is organised in different calls for proposals that are open in a pre-defined period of time where you can share your proposals with us. If you have an idea that does not fit with active calls, you can also share it with us through our suggestion box “Move your ideas forward”.

AlmirallShare is open to universities, public and private research entities, biotechs, start-ups, technological centers, and companies.

  1. Go to AlmirallShare
  2. Create an account in AlmirallShare Innovation platform, a secure tool to keep and manage your proposals
  3. Log in using your username and password
  4. Select the AlmirallShare call you would like to participate, and clic submit your proposal.
  5. Fulfil the proposal form. Please include an outline of your idea (max. 300 words) and a detailed description of your proposal attaching documents/publications that support the same
  6. Send us your proposal

All the information provided in the proposal should be non-confidential.  However, if there is confidential information in your proposal, please  Contact Us and we will manage it through a non-disclosure agreement.

Project budget is not a prerequisite.

Your proposal will be evaluated by a team of Almirall scientific experts. The evaluation process will last 8-10 weeks after call’s deadline. After this evaluation period, you will receive Almirall’s decision regarding the progression of your proposal.

Once your proposal has been selected, a Shared Innovation team member will help you during the grant acceptance process. An Almirall expert scientist will be assigned to collaborate with you on project definition as well as project follow-up.

The publication of project results is guaranteed, though Almirall reserves the right to review any publications prior to submission.

Contact Us and we will answer any further question you have regarding AlmirallShare

Still have questions?

Contact us